Article

Forbes on 2021-10-05 14:36

Johnson & Johnson Submits Booster Shot Data To FDA For Approval

The company has released data suggesting the second shot offers strong protection against Covid-19.

Related news

Johnson & Johnson requests FDA approval for COVID booster shot pressherald.com
United States
Pfizer submits data to FDA for COVID-19 vaccine booster authorization amny.com
Germany
Johnson & Johnson seeks FDA approval for COVID-19 booster shot in adults post-gazette.com
FDA delays booster shot approval israelnationalnews.com
Aerie submits second drug for FDA approval bizjournals.com
BJohnson & Johnson Sends Booster Data To FDA. Here's What Comes Next.3 min read barrons.com
FDA review of Johnson & Johnson booster finds potential benefit in second dose — with limited data post-gazette.com
FDA review of Johnson & Johnson booster finds potential benefit in second dose, with limited data Seattle Times
United States
Philip Morris submits a tobacco vaporizer for FDA approval engadget
Japan
Biogen Submits Promising Alzheimer’s Drug Aducanumab to FDA for Approval observer.com
FDA advisers recommend Johnson & Johnson's booster shot israelnationalnews.com
Israel , New York
Pfizer seeking FDA approval for COVID-19 vaccine booster dose nj.com
California , Germany
FDA panel recommends booster shot of Johnson & Johnson COVID vaccine oregonlive.com
California , Philadelphia , Bay Shore , University Hospital , South Shore
PAmgen submits data on cancer drug Kyprolis to FDA pacbiztimes.com
COVID-19 booster shots for kids get FDA approval reviewjournal.com
Pfizer submits early data on boosters’ protection to FDA pressherald.com
Europe , New York
Johnson & Johnson seeks FDA authorization of Covid booster shot POLITICO
White House defends touting booster-shot plan before FDA approval New York Post
Top FDA vaccine regulators quit over COVID booster shot approval israelnationalnews.com